• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明尼苏达州奥姆斯特德县成人多囊肾病的流行病学研究:1935 - 1980年

Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980.

作者信息

Iglesias C G, Torres V E, Offord K P, Holley K E, Beard C M, Kurland L T

出版信息

Am J Kidney Dis. 1983 May;2(6):630-9. doi: 10.1016/s0272-6386(83)80044-4.

DOI:10.1016/s0272-6386(83)80044-4
PMID:6846334
Abstract

Between January 1, 1935 and December 31, 1980, adult polycystic kidney disease (APKD) was diagnosed in 40 residents of Olmsted County, Minnesota, resulting in an age- and sex-adjusted annual incidence rate of 1.38/100,000 person-years. In addition, 16 cases were detected at autopsy, increasing the rate to 2.06. It is estimated that 16 additional cases would have been discovered had all deaths come to autopsy, resulting in a rate of 2.75, or approximately twice the incidence rate of cases diagnosed during life. Because of improvements in medical care and diagnostic techniques, APKD has been diagnosed earlier and more frequently in the recent decades. This, along with therapeutic advances, explains the improvement in kidney and patient survival for the patients diagnosed during 1956-1980, as compared to those diagnosed during 1935-1955. Normotension at diagnosis tended to be associated with better kidney and/or patient survival. Cardiovascular disease was the leading cause of death.

摘要

1935年1月1日至1980年12月31日期间,明尼苏达州奥尔姆斯特德县的40名居民被诊断患有成人多囊肾病(APKD),年龄和性别调整后的年发病率为1.38/100,000人年。此外,尸检时发现了16例病例,使发病率提高到2.06。据估计,如果所有死亡病例都进行尸检,还会发现另外16例病例,发病率将达到2.75,约为生前诊断病例发病率的两倍。由于医疗护理和诊断技术的进步,近几十年来APKD的诊断时间更早、频率更高。这与治疗进展一起,解释了1956 - 1980年期间诊断出的患者与1935 - 1955年期间诊断出的患者相比,肾脏和患者生存率有所提高的原因。诊断时血压正常往往与更好的肾脏和/或患者生存率相关。心血管疾病是主要死因。

相似文献

1
Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980.明尼苏达州奥姆斯特德县成人多囊肾病的流行病学研究:1935 - 1980年
Am J Kidney Dis. 1983 May;2(6):630-9. doi: 10.1016/s0272-6386(83)80044-4.
2
Adult polycystic kidney disease in Hong Kong Chinese: an autopsy study.香港华人成人多囊肾病:一项尸检研究。
Pathology. 1993 Jul;25(3):229-32. doi: 10.3109/00313029309066577.
3
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades.明尼苏达州奥尔姆斯特德县多发性骨髓瘤的发病率:60年趋势
Cancer. 2004 Dec 1;101(11):2667-74. doi: 10.1002/cncr.20652.
4
Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.1970年至2010年明尼苏达州奥尔姆斯特德县克罗恩病和溃疡性结肠炎的发病率及患病率
Clin Gastroenterol Hepatol. 2017 Jun;15(6):857-863. doi: 10.1016/j.cgh.2016.10.039. Epub 2016 Nov 14.
5
Incidence of leukemia in Olmsted County, Minnesota, 1975 through 1989.明尼苏达州奥姆斯特德县1975年至1989年白血病发病率。
Mayo Clin Proc. 1994 Apr;69(4):315-22. doi: 10.1016/s0025-6196(12)62214-9.
6
A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota.明尼苏达州奥尔姆斯特德县多发性硬化症流行病学的重新评估。
Neurology. 1990 May;40(5):780-6. doi: 10.1212/wnl.40.5.780.
7
[The association of polycystic kidneys with intracranial aneurysms (author's transl)].多囊肾与颅内动脉瘤的关联(作者译)
No To Shinkei. 1980 Mar;32(3):321-5.
8
Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945.明尼苏达州奥尔姆斯特德县1978年至1990年多发性骨髓瘤的发病率,并回顾1945年以来的发病趋势。
J Clin Oncol. 1994 Aug;12(8):1577-83. doi: 10.1200/JCO.1994.12.8.1577.
9
Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981.感染性心内膜炎。明尼苏达州奥姆斯特德县,1950年至1981年。
JAMA. 1985 Sep 6;254(9):1199-202. doi: 10.1001/jama.254.9.1199.
10
Cerebral aneurysms and polycystic kidney disease: a critical review.脑动脉瘤与多囊肾病:批判性综述
Can J Neurol Sci. 1992 May;19(2):222-7.

引用本文的文献

1
Autosomal Dominant Polycystic Kidney Disease: From Pathogenesis to Organoid Disease Models.常染色体显性多囊肾病:从发病机制到类器官疾病模型
Biomedicines. 2025 Jul 18;13(7):1766. doi: 10.3390/biomedicines13071766.
2
A Case of Horseshoe Kidney and Autosomal Dominant Polycystic Kidney Disease with Gene Mutation.马蹄肾合并常染色体显性多囊肾病伴基因突变1例
J Clin Med. 2025 Jun 5;14(11):4008. doi: 10.3390/jcm14114008.
3
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update.评论:托伐普坦用于常染色体显性多囊肾病(ADPKD)——最新进展
BMC Nephrol. 2025 Feb 14;26(1):79. doi: 10.1186/s12882-025-03960-4.
4
The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in cystic epithelial cells revealing a potential new target for polycystic kidney disease.肿瘤相关钙信号转导蛋白2(TACSTD2)癌基因在囊性上皮细胞中上调,揭示了多囊肾病的一个潜在新靶点。
PLoS Genet. 2024 Dec 12;20(12):e1011510. doi: 10.1371/journal.pgen.1011510. eCollection 2024 Dec.
5
Prospects for gene therapy in polycystic kidney disease.多囊肾病的基因治疗前景。
Curr Opin Nephrol Hypertens. 2025 Jan 1;34(1):121-127. doi: 10.1097/MNH.0000000000001030. Epub 2024 Oct 3.
6
Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on idiosyncratic drug-induced liver injury liabilities.托伐普坦在常染色体显性多囊肾病中的安全性;聚焦于特异质性药物性肝损伤风险。
Toxicol Sci. 2025 Jan 1;203(1):11-27. doi: 10.1093/toxsci/kfae142.
7
Applying a Deep Learning Model for Total Kidney Volume Measurement in Autosomal Dominant Polycystic Kidney Disease.应用深度学习模型测量常染色体显性多囊肾病中的总肾体积
Bioengineering (Basel). 2024 Sep 26;11(10):963. doi: 10.3390/bioengineering11100963.
8
Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.多囊肝病的临床表现、流行病学、遗传基础、潜在分子靶点及当前治疗方法
Orphanet J Rare Dis. 2024 Apr 26;19(1):175. doi: 10.1186/s13023-024-03187-w.
9
Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study.常染色体显性多囊肾病中的肾脏能量代谢与囊肿负荷:一项初步研究。
Am J Kidney Dis. 2024 Sep;84(3):286-297.e1. doi: 10.1053/j.ajkd.2024.02.016. Epub 2024 Apr 15.
10
The Rat: A Preclinical Model of Polycystic Kidney Disease.大鼠:多囊肾病的临床前模型
Biomedicines. 2024 Feb 3;12(2):362. doi: 10.3390/biomedicines12020362.